Drug Type CAR-T |
Synonyms Dual CAR T 2(Celyad), Dual CAR-T 2(Celyad), Dual CART 2(Celyad) |
Target |
Action inhibitors |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), MICA inhibitors(MHC class I polypeptide-related sequence A inhibitors), MICB inhibitors(MHC class I polypeptide-related sequence B inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | Belgium | 06 Sep 2023 |